Phase 4 N=50 Randomized Triple-blind Treatment

The Effect of Adding Sufentanyl to Bupivacaine in Transversus Abdominis Plane Block to Reduce the Narcotic Dosage and Pain After Cesarean Delivery

Pain

Bottom Line

View on ClinicalTrials.gov: NCT01516268 ↗

Enrolled (actual)

Serious AEs

8.0%

Results posted

Mar 2013

Primary outcome: Primary: Narcotic Dosage

Study Design & Population

Study type: Interventional
Phase: Phase 4
Interventions: Sufentanyl (Drug)
Age: Adult · 18+ yrs
Sex: Female
Sponsor: Tehran University of Medical Sciences
Primary completion: Feb 2013

Outcome Measures

Outcome	Result	p-value
PRIMARY Narcotic Dosage	37.2; 52.8	—
PRIMARY Narcotic Dosage	37.2; 52.8	—
SECONDARY Pain	—	—

Summary

Adding sufentanyl to bupivacain in Transversus Abdominis Plane (TAP) block under ultrasound guide can reduce narcotic dosage, side effects and pain after cesarean delivery.

Eligibility Criteria

Inclusion Criteria

female 18 to 40 Years
class ASA 1 and 2
candidates for elective cesarean section

Exclusion Criteria

renal failure
liver failure
cardiac disorder
coagulopathy
hepatomegaly
splenomegaly
drug sensitivity and abuse
morbid obesity
smoking
history of post operative nausea and vomiting
motion sickness
local hypoesthesia

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01516268). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.